Coherus Oncology CHRS
NASDAQ CHRS
$0.77 +0.02 (+2.82%)
At close: Nov 6, 2026 · 4:00 PM EST

Coherus Oncology (CHRS) Sale and Maturity of Investments (2017 - 2026)

Updated

Analysis

Coherus Oncology (CHRS) Sale and Maturity of Investments (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 308.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 315.51 Bn 288.75 Bn - 88.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 2.53 Bn
10 Coherus Oncology 119.30 Mn -516.84 Mn 10.07 Mn 43.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.54 Mn
Mar 31, 2026 38.14 Mn
Dec 31, 2025 19.81 Mn
Mar 31, 2024 14.89 Mn
Dec 31, 2023 36.21 Mn
Sep 30, 2023 43.40 Mn
Jun 30, 2023 47.25 Mn
Mar 31, 2023 17.50 Mn
Dec 31, 2021 36.99 Mn
Sep 30, 2021 47.70 Mn
Dec 31, 2020 211.00 Mn
Dec 31, 2019 5.40 Mn
Sep 30, 2019 6.00 Mn
Dec 31, 2018 16.00 Mn
Sep 30, 2018 14.00 Mn
Dec 31, 2017 14.50 Mn
Sep 30, 2017 45.00 Mn
API Access

Coherus Oncology Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=CHRS&period=max&api_key=YOUR_API_KEY